Lexicon Pharmaceuticals, Inc. announced on July 18, 2023, Frank P. Palantoni notified his decision to resign from board of directors, effective July 27, 2023. Mr. Palantoni?s resignation was not as a result of any disagreement with the Company on any matter relating to the Company?s operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.82 USD | -0.55% | +4.00% | +18.95% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.95% | 658M | |
+18.15% | 124B | |
+18.02% | 112B | |
-12.75% | 22.22B | |
+5.07% | 22.94B | |
-39.94% | 16.87B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- LXRX Stock
- News Lexicon Pharmaceuticals, Inc.
- Lexicon Pharmaceuticals, Inc. Announces Resignation of Frank P. Palantoni from Board of Directors, Effective July 27, 2023